Abstract
The studies of right-sided heart valve disease and of mixed valve disease have received less attention than those of pure left-sided valve disease; this is a consequence of fewer data and less interest in the right-sided valves and of even less data concerning mixed left-sided valve disease. However recognition that severe tricuspid and pulmonic regurgitation lead to increased morbidity and mortality has spurred increased study and development of newer interventions for those lesions. There is also renewed interest in the fate of mixed left-sided disease following transcatheter treatment of aortic valve disease. The aim of this chapter is to summarize recent advances in the diagnosis and treatment of right-sided valve disease and mixed left-sided valve disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
